View in EDS

Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial.

Saved in:
Bibliographic Details
Title: Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial.
Authors: Pinazo, Maria-Jesus1,2,3 (AUTHOR) mpinazo@dndi.org, Forsyth, Colin2 (AUTHOR), Losada, Irene1 (AUTHOR), Esteban, Elena Trigo4 (AUTHOR), García-Rodríguez, Magdalena5 (AUTHOR), Villegas, Maria Luz6 (AUTHOR), Molina, Israel3,7 (AUTHOR), Crespillo-Andújar, Clara3,4,8 (AUTHOR), Gállego, Montserrat1,3,9 (AUTHOR), Ballart, Cristina1,9 (AUTHOR), Ramirez, Juan Carlos10 (AUTHOR), Aden, Tilman11 (AUTHOR), Hoerauf, Achim11,12 (AUTHOR), Pfarr, Kenneth11,12 (AUTHOR), Vaillant, Michel13 (AUTHOR), Marques, Tayná2 (AUTHOR), Fernandes, Jayme2 (AUTHOR), Blum, Bethania2 (AUTHOR), Ribeiro, Isabela2 (AUTHOR), Sosa-Estani, Sergio2,14 (AUTHOR)
Source: Lancet Infectious Diseases. Apr2024, Vol. 24 Issue 4, p395-403. 9p.
Database: Academic Search Ultimate
Description
ISSN:14733099
DOI:10.1016/S1473-3099(23)00651-5